Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elai Davicioni

Showing results (21-30 of 265) with videos related to

Pageof 27
Sort By:
Journal of Cancer Research and Clinical Oncology|March 8, 2018
Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancerHatem Abou-Ouf, Mohammed Alshalalfa, Mandeep Takhar, et al.
BMC Genomics|February 20, 2019
Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancerYe Feng, Varune Rohan Ramnarine, Robert Bell, et al.
Exploration of Targeted Anti-Tumor Therapy|October 28, 2024
Upper tract urothelial cancer (UTUC) genomic profiling and correlation regarding benefit of platinum-based chemotherapyMin Woo Hwang, Jasmine Kauffeld, Sarah Belay, et al.
Prostate Cancer and Prostatic Diseases|May 14, 2022
High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatmentsAdam B Weiner, Christina Y Yu, Mitali Kini, et al.
JCO Precision Oncology|August 18, 2023
Transcriptomic Signatures Associated With Outcomes in Recurrent Prostate Cancer Treated With Salvage Radiation, Androgen-Deprivation Therapy, and Enzalutamide: Correlative Analysis of the STREAM TrialRhonda L Bitting, Yuan Wu, Jason A Somarelli, et al.
Frontiers in Genetics|February 29, 2012
Genomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as BiomarkersIsmael A Vergara, Nicholas Erho, Timothy J Triche, et al.
International Journal of Radiation Oncology, Biology, Physics|June 26, 2020
Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine TumorsShervin Tabrizi, Mohammed Alshalalfa, Brandon A Mahal, et al.
European Urology Oncology|June 17, 2020
Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical ProstatectomyAdam B Weiner, Farzana A Faisal, Elai Davicioni, et al.
Journal of Translational Genetics and Genomics|April 30, 2021
Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastasesYuan C Ding, Huiqing Wu, Elai Davicioni, et al.
Oncotarget|April 18, 2013
Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study groupKetan Badani, Darby J S Thompson, Christine Buerki, et al.
Pageof 27

Showing results (21-30 of 265) with videos related to

Sort By:
Pageof 27
Journal of Cancer Research and Clinical Oncology|March 8, 2018
Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancerHatem Abou-Ouf, Mohammed Alshalalfa, Mandeep Takhar, et al.
BMC Genomics|February 20, 2019
Metagenomic and metatranscriptomic analysis of human prostate microbiota from patients with prostate cancerYe Feng, Varune Rohan Ramnarine, Robert Bell, et al.
Exploration of Targeted Anti-Tumor Therapy|October 28, 2024
Upper tract urothelial cancer (UTUC) genomic profiling and correlation regarding benefit of platinum-based chemotherapyMin Woo Hwang, Jasmine Kauffeld, Sarah Belay, et al.
Prostate Cancer and Prostatic Diseases|May 14, 2022
High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatmentsAdam B Weiner, Christina Y Yu, Mitali Kini, et al.
JCO Precision Oncology|August 18, 2023
Transcriptomic Signatures Associated With Outcomes in Recurrent Prostate Cancer Treated With Salvage Radiation, Androgen-Deprivation Therapy, and Enzalutamide: Correlative Analysis of the STREAM TrialRhonda L Bitting, Yuan Wu, Jason A Somarelli, et al.
Frontiers in Genetics|February 29, 2012
Genomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as BiomarkersIsmael A Vergara, Nicholas Erho, Timothy J Triche, et al.
International Journal of Radiation Oncology, Biology, Physics|June 26, 2020
Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine TumorsShervin Tabrizi, Mohammed Alshalalfa, Brandon A Mahal, et al.
European Urology Oncology|June 17, 2020
Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical ProstatectomyAdam B Weiner, Farzana A Faisal, Elai Davicioni, et al.
Journal of Translational Genetics and Genomics|April 30, 2021
Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastasesYuan C Ding, Huiqing Wu, Elai Davicioni, et al.
Oncotarget|April 18, 2013
Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study groupKetan Badani, Darby J S Thompson, Christine Buerki, et al.
Pageof 27